Literature DB >> 2723615

Measurement of avidity of specific IgG for verification of recent primary rubella.

K Hedman1, S A Rousseau.   

Abstract

Sixty-four subjects' serum samples, positive or equivocal by rubella IgM assays and containing rubella IgG, were examined for the avidity of rubella IgG. Four of the sera originated from rubella reinfections; others had false-positive IgM results due to interference by parvovirus infection or by other mechanisms; and the remaining were sera from the acute phase or convalescence of primary rubella. A novel IgG avidity test, avidity-ELISA, and a semiquantitative haemolysis typing assay were used. According to the avidity-ELISA, 29 subjects had recent primary rubella (low IgG avidity), and another 29 had previous rubella immunity (high IgG avidity), whereas 6 serum samples gave borderline avidity values. Comparison of these results with pre-existing clinical records and laboratory data showed that all samples with low IgG avidity were obtained during or shortly after acute primary rubella. All sera with high IgG avidity originated from the previously immune subjects; the rubella reinfections were confined within this group. Five of the six sera with borderline avidity values were obtained within 2 months from primary rubella. In conclusion, the measurement of IgG avidity is a powerful tool for the distinction of acute or recent primary rubella from pre-existing rubella immunity, including rubella reinfections.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2723615     DOI: 10.1002/jmv.1890270406

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  28 in total

1.  Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects.

Authors:  T Lazzarotto; P Spezzacatena; P Pradelli; D A Abate; S Varani; M P Landini
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

2.  Use of an immunoglobulin G avidity test to discriminate between primary and secondary dengue virus infections.

Authors:  Vanda Akico Ueda Fick de Souza; Silvana Fernandes; Evaldo Stanislau Araújo; Adriana Fumie Tateno; Olímpia M N P F Oliveira; Renato Reis Oliveira; Cláudio Sérgio Pannuti
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

3.  Use of four dengue virus antigens for determination of dengue immune status by enzyme-linked immunosorbent assay of immunoglobulin G avidity.

Authors:  Séverine Matheus; Xavier Deparis; Bhety Labeau; Josiane Lelarge; Jacques Morvan; Philippe Dussart
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

4.  Discrimination between primary and secondary dengue virus infection by an immunoglobulin G avidity test using a single acute-phase serum sample.

Authors:  Séverine Matheus; Xavier Deparis; Bhety Labeau; Josiane Lelarge; Jacques Morvan; Philippe Dussart
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

5.  Evaluation of the rubella surveillance system in Quebec.

Authors:  L Perron; P De Wals; F Milord
Journal:  Can J Infect Dis       Date:  2000-11

Review 6.  Laboratory diagnosis of rubella: past, present and future.

Authors:  J E Cradock-Watson
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

7.  A serological follow-up of toxocariasis patients after chemotherapy based on the detection of IgG, IgA, and IgE antibodies by enzyme-linked immunosorbent assay.

Authors:  Guita Rubinsky Elefant; Sumie Hoshino Shimizu; Maria Carmen Arroyo Sanchez; Cristina Miuki Abe Jacob; Antonio Walter Ferreira
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

8.  Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus.

Authors:  J E Clements; R C Montelaro; M C Zink; A M Amedee; S Miller; A M Trichel; B Jagerski; D Hauer; L N Martin; R P Bohm
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

9.  The avidity of specific IgM detected in primary rubella and reinfection.

Authors:  H I Thomas; P Morgan-Capner
Journal:  Epidemiol Infect       Date:  1990-06       Impact factor: 2.451

10.  IL-12 receptor β1 deficiency alters in vivo T follicular helper cell response in humans.

Authors:  Nathalie Schmitt; Jacinta Bustamante; Laure Bourdery; Salah Eddine Bentebibel; Stephanie Boisson-Dupuis; Fran Hamlin; Mau V Tran; Derek Blankenship; Virginia Pascual; Daniel A Savino; Jacques Banchereau; Jean-Laurent Casanova; Hideki Ueno
Journal:  Blood       Date:  2013-03-08       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.